Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Gonzalez Jimenez (Valencia, Spain), R. Méndez (Valencia, Spain), L. Feced (Valencia, Spain), M. Fernández-Pérez (Murcia, Spain), R. González-Conejero (Murcia, Spain), C. Martínez (Murcia, Spain), A. Latorre (Valencia, Spain), A. Moscardó (Valencia, Spain), R. Menéndez (Valencia, Spain). Neutrophil extracellular traps levels are associated to severity and complications in community-acquired pneumonia. 2341

Member's Comments

No comment yet.

Related content which might interest you: Systemic cytokine levels in community-acquired pneumonia and their association with disease severity Source: Eur Respir J 2002; 20: 990-995 Year: 2002 D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Macrophage activation in exacerbated COPD with and without community-acquired pneumonia Source: Eur Respir J 2010; 36: 285 Year: 2010 Estimation of inflammatory process activity in community-acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer Source: Eur Respir Rev 2008; 17: 83-85 Year: 2008 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression Source: Eur Respir J 2012; 40: 1201-1210 Year: 2012 Enhanced PMN response in chronic bronchitis and community-acquired pneumonia Source: Eur Respir J 2004; 24 : 772-778 Year: 2004 Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002 Lactate is an independent marker of severity in hospitalised patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Impact of neutrophil apoptosis on clinical outcomes in nonresponding community-acquired pneumonia Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 Serum levels of IL-6 in severe community-acquired pneumonia Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010 Local and systemic cytokine profiles in patients with non-severe and severe community-acquired pneumonia Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Factors associated with unknown aetiology in patients with community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 560s Year: 2002 Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia Source: Eur Respir J 2007; 30: 517-524 Year: 2007 Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 347s Year: 2006